Skip to content

HIV cure at CROI: new data on antibodies, vaccines and genetically engineered T-cells

Image from Jim Riley's Cure Workshop presentation at CROI 2020.

Child with HIV maintains viral suppression for three years off treatment

Child with HIV maintains viral suppression for three years off treatment

HIV vaccine that generates broadly neutralising antibodies passes first safety and proof-of-concept study in humans

HIV envelope trimer (triple-component) molecule BG505 SOSIP.

London patient remains HIV-free after 2.5 years off treatment

Ravindra Gupta first presenting the case at CROI 2019 in Seattle. Photo by Liz Highleyman.

People with HIV more willing to consider a medication offering a 'cure' for HIV than one providing 'clinical remission'

Image: Kostex/Shutterstock.com

“I’m prepared to die to be cured of HIV” – what did people mean when they said this?

Image: Chinnapong/Shutterstock.com

Many people living with HIV unwilling to interrupt treatment for prolonged periods during HIV cure trials

Will post-treatment controllers guide us towards an HIV cure?

Image: nevodka/Shutterstock.com

Second case of unintended HIV transmission during HIV cure study prompts questions about PrEP provision

Image: Adam Gregor/Shutterstock.com